Has anyone else noticed a change of trading pattern since the quarterly? Starting to act like a normal stock.....No arguments entered into....Just something I've noticed....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%